Comparing the current results to its competitors, The Oncology Institute Inc reported Revenue increase in the 1 quarter 2026 by 41.22 % year on year. The sales growth was above The Oncology Institute Inc 's competitors' average revenue growth of 7.16 %, achieved in the same quarter.
The Oncology Institute Inc , slower than the average decrease reported by the company's competitors of -65.38 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -65.38 %
The Oncology Institute Inc 's Comment on Competition and Industry Peers
The Oncology Institute, Inc. (TOI) operates within the U.S. healthcare industry, competing with both local and national cancer care providers, including health system-affiliated practices. Its primary competitors are traditional oncology physician practices such as American Oncology Network, Inc., U.S. Oncology Network, Inc., and OneOncology, Inc., which primarily operate under fee-for-service reimbursement models. Secondary competitors include specialty benefit managers like Evolent Health, Thyme Care, and OncoHealth, which seek to influence provider and patient behavior through treatment authorization and directing patients to lower-cost care sites. These benefit managers have limited influence over physician behavior and referrals compared to managed healthcare practices like TOI. TOI competes based on patient experience, quality of care, health outcomes, total cost of care, brand identity, and trust.
Strong sales growth of 41.22 % in Overall company contributed to The Oncology Institute Inc increase in total revenue by 41.22 % The Oncology Institute Inc improved its market share in this segment, to approximately 0.07 %.
December 18, 2024
As cancer care remains a focal point in the American healthcare landscape, Florida Blue is making strides in enhancing oncology services for its members. Recently, the nonprofit health insurer announced a new initiative designed to improve patient outcomes, experiences, and overall quality of life by streamlining access to affordable and high-quality cancer care. This initiative is particularly critical in a landscape where patients often face significant hurdles in obtaining timely and effective treatment.The newly introduced program aims to address these challenges by easing the process of connecting patients with oncology care providers. By centralizing resources and support, Florida Blue is attempting to...
Publicly Traded Peers of The Oncology Institute Inc
Concord Medical Services Holdings Ltd Share Performance
+6.79%
This Year
Concord Medical Services Holdings Ltd
Profile
Concord Medical Services Holdings Ltd operates a network of radiotherapy and diagnostic imaging centers in China. The company partners with hospitals to provide advanced medical technology and expertise, offering comprehensive cancer treatment services to patients. By leveraging their extensive network, Concord Medical aims to improve healthcare accessibility, quality, and affordability across the country.
Pfizer Inc operates as a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing innovative medicines. Its business model emphasizes significant investment in research and development to build a diverse portfolio of therapies across various therapeutic areas, while leveraging strategic alliances and collaborations to enhance commercialization and drive growth.
Merck & Co. Inc. operates primarily as a research-driven pharmaceutical company, focused on the development, manufacturing, and marketing of prescription drugs and vaccines globally. It aims to address unmet medical needs through innovative research, collaborations, and rigorous clinical trials, while promoting patient well-being and contributing to global healthcare with high-quality, affordable medications.
McKesson Corporations business model centers on healthcare distribution and technology solutions, supplying pharmaceuticals, medical supplies, and business services to pharmacies, hospitals, and healthcare providers. They emphasize efficiency and innovation in healthcare delivery.
Cardinal Health Inc operates as a prominent integrated healthcare services provider in the United States, specializing in the distribution of pharmaceuticals and medical products to various healthcare settings, including retail pharmacies and hospitals. The company enhances healthcare efficiency through a range of services such as inventory management, medication therapy management, and data analytics solutions aimed at optimizing operations and improving patient care.
Sources:
The Oncology Institute Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on The Oncology Institute Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
